Xiamen, China

Zhixiang He


Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhixiang He: Innovator in Pharmaceutical Compounds

Introduction

Zhixiang He is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds aimed at treating various diseases. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Zhixiang He's latest patents include the development of substituted penta-fused hexa-heterocyclic compounds. These compounds exhibit selective inhibition for PIKfyve kinase and are designed for use in preventing or treating tumor growth and metastasis. His second patent focuses on pyrimidine seven-membered-ring compounds, which are capable of inhibiting Mst1/2 protein kinase activity. These compounds have potential applications in tissue repair, stem cell proliferation, and the treatment of nervous disorders.

Career Highlights

Zhixiang He has worked with esteemed institutions such as Xiamen University and Anhui New Star Pharmaceutical Development Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of new pharmaceutical solutions.

Collaborations

Throughout his career, Zhixiang He has collaborated with notable colleagues, including Xianming Deng and Wei Peng Huang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing his innovative work.

Conclusion

Zhixiang He is a prominent figure in the field of pharmaceutical innovation, with a focus on developing compounds that address critical health issues. His contributions through patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…